About Le-Mantus Pharmaceuticals Private Limited
Data last updated:
Le-Mantus Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 24 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2006PTC145303. Its GSTIN is 05AABCL9023A1Z3 (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Asha Jain and Ashutosh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 25 Shivam Apttssector 15 Rohini Delhi, Delhi, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.31 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹34.48 Lakh (net margin 1.2%) and EBITDA of ₹1.22 Cr (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over five years.
The company is associated with 1 brand: Le-Mantus. As per MCA filings, the company has open charges of ₹12.89 Cr and satisfied charges of ₹10.31 Cr on record. Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it; 1 case is pending. The company has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹24 Lakh; the latest was in April 2019. Its 5 peer companies in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Cedric Pharmaceuticals Private Limited with revenue of ₹29.69 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lemantus.com.
Company details
Contact details
Le-Mantus Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is lemantus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address25 Shivam Apttssector 15 Rohini Delhi, Delhi, India
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Le-Mantus Pharmaceuticals operates one associated brand: Le-Mantus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Veterinary medicine manufacturing and supply in India. | lemantus.com |
Business activity
The main business activity of Le-Mantus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Financials of Le-Mantus Pharmaceuticals Private Limited
FY 2025 filings availableLe-Mantus Pharmaceuticals Private Limited reported revenue of ₹29.31 Cr (down 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Le-Mantus Pharmaceuticals Private Limited
Le-Mantus Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asha Jain | Director | 13 Jul 2017 | 9 Years 3 Months | Current |
| Ashutosh Gupta Also directs: Lemantus Industrial Infra Developers LLP, Manverse Pharma LLP, Medswik Pharma LLP and 1 more | Director | 07 Jul 2010 | 16 Years 3 Months | Current |
| Annu Gupta Also directs: Lemantus Industrial Infra Developers LLP, Manverse Pharma LLP, Medswik Pharma LLP and 1 more | Director | 07 Jul 2010 | 16 Years 3 Months | Current |
Peer comparison
Le-Mantus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Ventis Pharmaceuticals Private Limited | ₹29.55 Cr (FY 2025) | 32.0% | Ghaziabad, Uttar Pradesh, India | |||
| Pesino Pharmaceuticals Private Limited | ₹29.51 Cr (FY 2024) | 50.0% | Mumbai, Maharashtra, India | |||
| Le-Mantus Pharmaceuticals Private Limitedthis company | ₹29.31 Cr (FY 2024) | ₹34.48 Lakh | 1.2% | -27.0% | Delhi, India | |
| Stantech Pharmaceuticals Private Limited | ₹28.91 Cr (FY 2024) | 17.0% | Mumbai, Maharashtra, India | |||
| Goel Vet Pharma Private Limited | ₹28.84 Cr (FY 2024) | -7.0% | Chittorgarh, Rajasthan, India |
To see the full peer comparison of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Auditor
Le-Mantus Pharmaceuticals Private Limited is audited by ABHISHAKE KULDEEP & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHISHAKE KULDEEP & CO | FY 2023 | 021218N |
Shareholding
The shareholding of Le-Mantus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2025 | 101230891 | Others | ₹2.9 Cr | Open | |
| 11 Jun 2024 | 100955045 | Others | ₹9.99 Cr | Open | |
| 28 Jul 2018 | 100229031 | Others | ₹6.34 Cr | Satisfied | |
| 07 Feb 2017 | 100078410 | Others | ₹2.52 Cr | Satisfied | |
| 04 Oct 2012 | 10381327 | Hdfc Bank Limited | ₹95 Lakh | Satisfied |
To see the full charge records of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Le-Mantus Pharmaceuticals Private Limited has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹24 Lakh; the latest was in April 2019.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Dec 2016 | Funding round | ₹10 Lakh | Investors: an individual |
| Mar 2014 | Funding round | ₹5 Lakh | Investors: an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
To see the full deal history of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Le-Mantus Pharmaceuticals Private Limited has 13 court cases on record: 12 filed by Le-Mantus Pharmaceuticals, 1 filed against it. 1 case is pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against Dass Enterprises | Pending |
| District court, Solan, Himachal Pradesh | Court case (Motor Vehc Act) | Filed against the company by State of HP | Disposed |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against India Enterprises | Disposed |
| High Court, UTTARAKHAND | Court case (C482) | Filed by the company against State of Uttarakhand and Others | Disposed |
| District court, Dehradun, Uttarakhand | Criminal case | Filed by the company against R.R. Enterprises | Disposed |
To see the full case history of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Le-Mantus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Le-Mantus Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AABCL9023A1Z3 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Le-Mantus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Le-Mantus Pharmaceuticals Private Limited has 7 board changes on record since 2006: 5 appointments and 2 cessations. The latest: Asha Jain was appointed as Director on 13 Jul 2017.
12 earlier events are in the company report.
Frequently asked questions
Le-Mantus Pharmaceuticals is an active private limited company based in Delhi, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 24 January 2006 (20+ years old) and is registered under CIN U24233DL2006PTC145303.
Le-Mantus Pharmaceuticals has 3 current directors:
- Asha Jain - Director
- Ashutosh Gupta - Director
- Annu Gupta - Director
The latest financial statements of Le-Mantus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Le-Mantus Pharmaceuticals is 05AABCL9023A1Z3, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Le-Mantus Pharmaceuticals is U24233DL2006PTC145303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Le-Mantus Pharmaceuticals has 13 court cases on record: 12 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Le-Mantus Pharmaceuticals was incorporated on 24 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Le-Mantus Pharmaceuticals has 7 deals on record (4 secondary share transfers, 3 funding rounds), with disclosed funding of ₹24 Lakh; the latest was in April 2019.
The peers of Le-Mantus Pharmaceuticals by revenue are Cedric Pharmaceuticals Private Limited, Ventis Pharmaceuticals Private Limited, Pesino Pharmaceuticals Private Limited, Stantech Pharmaceuticals Private Limited, Goel Vet Pharma Private Limited, all in the Pharma industry (Animal Pharma, Pharmaceuticals), with the same principal business activity (wholesale trading).
Asha Jain was appointed as Director on 13 Jul 2017. Ram Richpal ceased to be Director on 30 Jul 2010. Ravinder Gupta ceased to be Director on 30 Jul 2010. Le-Mantus Pharmaceuticals has 7 board changes on record in total.
Le-Mantus Pharmaceuticals can be reached through the website lemantus.com. Its registered office is in Delhi, India.